Skip to content

Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea

Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03782844
Enrollment
100
Registered
2018-12-20
Start date
2019-01-02
Completion date
2019-10-15
Last updated
2021-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuous Positive Airway Pressure, Polysomnography, Sleep Apnea, Obstructive

Brief summary

Obstructive sleep apnea (OSA) is a common and frequently-occurring disease. The incidence of OSA is more than 4% in general population, and as high as 20% - 40% in the elderly. At present, CPAP machines commonly used for OSA treatment includes traditional pressure fixed single-level CPAP machine and automatic pressure regulation CPAP machine. Studies have shown that the CPAP treatment pressure of OSA patients is normally below 11 cmH2O. Since the condition of OSA patients and the required CPAP treatment pressure may change over time, a CPAP machine with automatic pressure regulation function may theoretically better meet the needs of treatment. However, a recent large-scale clinical study with an average follow-up of four years showed that there was little need to change CPAP treatment pressure after titration. Although different types of CPAP have different functions, the basic principle is to keep the upper airway open and unobstructed to eliminate sleep apnea and hypopnea by continuously applying positive pressure to the upper respiratory tract through an air pump. A complex CPAP machine with functions such as pressure regulation, boost delay, end-expiratory pressure release will cost more than a single-function CPAP machine. Some patients from poor areas, even with severe OSA, may give up treatment when they can not afford CPAP machines that have not yet been included in national health insurance in China. In view of the current economic level in China, it is urgent to find an inexpensive and effective CPAP machine for the treatment of OSA and related complications. Recently, Guangzhou Yinghui Medical Technology Co., Ltd.and State Key Laboratory of Respiratory Disease have developed a new simple CPAP machine. The CPAP treatment pressure is fixed at the factory to 6 cm H2O (SKL), 8 cm H2O (SKM) and 10 cm H2O (SKH). Compared to traditional CPAP machine, only a power switch button is attached on the body, and the additional adjustment devices including display screen are removed, which not only reduces the cost of the CPAP machine, but also facilitates the operation of patients.

Detailed description

Study Design: A randomized, cross-over and double blind study . Objective: To investigate the efficacy of simple device of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSA). Methods: A randomized, cross-over and double blind study would be performed on 100 OSA patients using both simple CPAP and traditional CPAP during overnight polysomnography. Pressure for CPAP treatment would be manual titrated. The sleep apnea hypopnea index (AHI), arousal index (ArI), Oxygen desaturation Index (ODI), sleep structure and the preference of CPAP model were to be observed.

Interventions

DEVICESimple CPAP+Conventional fixed CPAP

Patients used simple CPAP and conventional fixed CPAP during overnight polysomnography.

DEVICESimple CPAP + Auto CPAP

Patients used simple CPAP and Auto CPAP during overnight polysomnography.

Sponsors

State Key Laboratory of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Willing to participate after informed consent 2. Males and females, any race and aged≥18yeras 3. Objectively confirmed OSA with an apnoea-hypopnoea- index (AHI)≥5/h by overnight polysomnography

Exclusion criteria

1. Central Sleep Apnoea/Cheyne Stokes Respiration 2. Opioid or sedative use; Alcohol abuse 3. Nasal congestion or tonsils more than Ⅱ degrees enlarged 4. Optimal treatment CPAP pressure over 10cmH2O 5. Poor understanding or being disabled

Design outcomes

Primary

MeasureTime frameDescription
Apnea Hypopnea IndexOne full nightTotal number of apneas and hypopneas×60/total sleep time
Arousal IndexOne full nightTotal number of arousals×60/total sleep time
Oxygen Desaturation IndexOne full nightTotal number of oxygen desaturations≥3%×60/total sleep time
Sleep structureOne full nightSleep stage distribution(N1, N2, N3, NREM)
Adverse effectsOnefull nightUsing questionnaire to assess adverse effects including dyspnea, noise, bloating, et al

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026